Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Aug 1.

Published in final edited form as: Cell Immunol. 2021 May 21;366:104383. doi: 10.1016/j.cellimm.2021.104383

Table 1.

Disease phenotype of C57BL/6 and SJL active immunization EAE

	C57BL/6			SJL
	CFA: MOG₃₅-₅₅	GP: MOG₃₅-₅₅	t-testp value	CFA: PLP_139–151	GP: PLP_139–151	t-testp value
Incidence	19/25 (76%)	24/30 (80%)		34/45 (76%)	30/40 (75%)
Survival	100%	100%		97%	90%
OnsetDay ± SD	12.3 ± 1.7	11.6 ± 2.9	0.2688	13.0 ± 4.4	15.1 ± 2.6	0.7110
PeakEAE Score ± SD	2.4 ± 0.8	2.0 ± 0.7	0.1456	2.3 ± 0.8	2.2 ± 0.8	0.3299